A Novel NanoDisc Platform for Induction of Antigen-Specific Immune Tolerance

Time: 12:00 pm
day: Day One


  • Examine how subcutaneous administration of NanoDisc targets multiple lymphoid tissues and immune system organs
  • Discover how NanoDisc carrying autoantigens induce antigen-specific T-Regs and Tr1 cells, while reducing autoreactive IgG response
  • Learn how NanoDisc therapy exerts robust efficacy in preclinical models of Multiple Sclerosis and Type 1 Diabetes